Form4insider filings, from the source

SEC Form 4/A · accession 0001683168-18-001857

Medicine Man Technologies, Inc. · MDCL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Andrew Johns Williams
Director · 10% Owner
Period of report
Jun 8, 2018
Accepted (ET)
Jul 3, 2018 · 3:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001622879

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jun 8, 2018S8,200$1.70D2,453,536ISee Footnote
Common StockF1Jun 11, 2018S1,200$1.75D2,452,336ISee Footnote
Common StockF1Jun 11, 2018S5,000$1.7668D2,447,336ISee Footnote
Common StockF1Jun 11, 2018S4,000$1.7525D2,443,336ISee Footnote
Common StockF1Jun 11, 2018S6,000$1.73D2,437,336ISee Footnote
Common StockF1Jun 12, 2018S4,500$1.6711D2,432,836ISee Footnote
Common StockF1Jun 13, 2018S5,000$1.76D2,427,836ISee Footnote
Common StockF1Jun 13, 2018S5,000$1.76D2,422,836ISee Footnote
Common StockF1Jun 13, 2018S5,000$1.76D2,417,836ISee Footnote
Common StockF1Jun 13, 2018S5,000$1.7588D2,412,836ISee Footnote
Common StockF1Jun 13, 2018S5,000$1.79D2,407,836ISee Footnote
Common StockF1Jun 13, 2018S5,000$1.79D2,402,836ISee Footnote
Common StockF1Jun 13, 2018S5,000$1.79D2,397,836ISee Footnote
Common StockF1Jun 13, 2018S5,000$1.79D2,392,836ISee Footnote
Common StockF1Jun 13, 2018S5,000$1.79D2,387,836ISee Footnote
Common StockF1Jun 15, 2018S5,000$1.6942D2,382,836ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses